Anuncio
Anuncio

IMVT

IMVT logo

Immunovant, Inc. Common Stock

39.48
USD
Patrocinado
+0.87
+2.25%
30 jul, 15:59 UTC -4
Cerrado
exchange

Pre-mercado

39.69

+0.21
+0.52%

Panorámica financiera de Immunovant, Inc. Common Stock

Cap. de Mercado
8.15B
Beta
0.67
Beneficios Por Acción (BPA)
-2.69
Ratio Precio/Valor (P/V) Contable
4.56
Margen de explotación
--
Ratio de Endeudamiento total (D/C)
0.00%
Ratio PER
--
Rentabilidad sobre recursos propios (ROE)
-63.17%
Ratio de liquidez
15.74%
Flujo de caja libre
-312.25M
Perfil de IMVT

Gráfico de Beneficios

Beneficios de IMVT

Últimas noticias y pronósticos

Ver todo

Valores en tendencia

Sandisk Corporation Common Stock logo
Sandisk Corporation Common Stock$1,279.96
+25.99%
Micron Technology, Inc. logo
Micron Technology, Inc.$874.66
+18.36%
Madrigal Pharmaceuticals, Inc. Common Stock logo
Madrigal Pharmaceuticals, Inc. Common Stock$493.11
-9.83%
Tradeweb Markets Inc. Class A Common Stock logo
Tradeweb Markets Inc. Class A Common Stock$97.80
-9.60%
S
SK hynix Inc. - ADR$149.00
+17.52%
The Sherwin-Williams Company logo
The Sherwin-Williams Company$344.84
+0.28%
W.W. Grainger, Inc. logo
W.W. Grainger, Inc.$1,355.49
-0.25%
Anuncio